Clinical Significance of Subclinical Myocardial Involvement in Recovered COVID-19 Patients Using Cardiovascular Magnetic Resonance (R-COVID-CMR) (R-COVID-CMR)
Sponsor: The University of Hong Kong
This NA trial investigates Covid19 and Viral Respiratory Infection and is currently completed. The University of Hong Kong leads this study, which shows 6 recorded versions since 2021 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
6 versions recorded-
Jun 2025 — Present [monthly]
Completed NA
Status: Recruiting → Completed
-
Sep 2024 — Jun 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jan 2024 — Jul 2024 [monthly]
Recruiting NA
-
Oct 2021 — Jan 2024 [monthly]
Recruiting NA
▶ Show 1 earlier version
-
May 2021 — Oct 2021 [monthly]
Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- The University of Hong Kong
For direct contact, visit the study record on ClinicalTrials.gov .